- Home
- COGT vs FWRD Comparison
COGT vs FWRD Comparison
Compare COGT & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- FWRD
- Stock Information
- Founded
- COGT 2014
- FWRD 1981
- Country
- COGT United States
- FWRD United States
- Employees
- COGT N/A
- FWRD N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- FWRD Oil Refining/Marketing
- Sector
- COGT Health Care
- FWRD Consumer Discretionary
- Exchange
- COGT Nasdaq
- FWRD Nasdaq
- Market Cap
- COGT 1.0B
- FWRD 970.3M
- IPO Year
- COGT 2018
- FWRD 1993
- Fundamental
- Price
- COGT $8.00
- FWRD $27.94
- Analyst Decision
- COGT Buy
- FWRD Hold
- Analyst Count
- COGT 6
- FWRD 4
- Target Price
- COGT $14.17
- FWRD $30.00
- AVG Volume (30 Days)
- COGT 1.3M
- FWRD 524.5K
- Earning Date
- COGT 03-04-2025
- FWRD 02-26-2025
- Dividend Yield
- COGT N/A
- FWRD N/A
- EPS Growth
- COGT N/A
- FWRD N/A
- EPS
- COGT N/A
- FWRD N/A
- Revenue
- COGT N/A
- FWRD $2,179,844,000.00
- Revenue This Year
- COGT N/A
- FWRD $86.25
- Revenue Next Year
- COGT N/A
- FWRD $8.15
- P/E Ratio
- COGT N/A
- FWRD N/A
- Revenue Growth
- COGT N/A
- FWRD 78.71
- 52 Week Low
- COGT $5.73
- FWRD $11.21
- 52 Week High
- COGT $12.61
- FWRD $40.92
- Technical
- Relative Strength Index (RSI)
- COGT 41.50
- FWRD 31.14
- Support Level
- COGT $7.88
- FWRD $30.28
- Resistance Level
- COGT $8.37
- FWRD $32.15
- Average True Range (ATR)
- COGT 0.42
- FWRD 1.42
- MACD
- COGT -0.11
- FWRD -0.29
- Stochastic Oscillator
- COGT 5.85
- FWRD 7.23
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight and Intermodal. The company generates maximum revenue from the Expedited Freight segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.